Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.
作者信息
Smith Steven M, Gurka Matthew J, Winterstein Almut G, Handberg Eileen, Pepine Carl J, Cooper-DeHoff Rhonda M
机构信息
Department of Pharmacotherapy & Translational Research (S.M.S., R.M.C.-D.), College of Medicine, University of Florida, Gainesville.
Department of Pharmaceutical Outcomes & Policy (S.M.S., A.G.W.), College of Medicine, University of Florida, Gainesville.
出版信息
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e005979. doi: 10.1161/CIRCOUTCOMES.119.005979. Epub 2020 Feb 3.
Abstract
摘要
相似文献
1
Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.重新定义难治性高血压：2018年与2008年美国心脏协会难治性高血压定义相关的心血管风险比较。
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e005979. doi: 10.1161/CIRCOUTCOMES.119.005979. Epub 2020 Feb 3.
2
Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From China.2017年美国心脏病学会/美国心脏协会高血压指南的全球影响：来自中国的视角
Circulation. 2018 Feb 6;137(6):546-548. doi: 10.1161/CIRCULATIONAHA.117.032890.
3
Medication adherence and resistant hypertension.药物依从性与难治性高血压
J Hum Hypertens. 2015 Apr;29(4):213-8. doi: 10.1038/jhh.2014.73. Epub 2014 Sep 11.
4
Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India.2017年美国心脏协会/美国心脏病学会高血压指南的全球影响：来自印度的视角
Circulation. 2018 Feb 6;137(6):549-550. doi: 10.1161/CIRCULATIONAHA.117.032877.
5
Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From Japan.2017年美国心脏协会/美国心脏病学会高血压指南的全球影响：来自日本的观点
Circulation. 2018 Feb 6;137(6):543-545. doi: 10.1161/CIRCULATIONAHA.117.032851.
6
The New ACC/AHA Hypertension Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.美国心脏病学会/美国心脏协会成人高血压预防、检测、评估和管理新指南
Am J Hypertens. 2018 Jan 12;31(2):133-135. doi: 10.1093/ajh/hpx207.
7
Clinical and translational science in cardiovascular research: highlights from the American Heart Association Scientific Sessions 2017: Changing view on the concept of cardiovascular risk and blood pressure targets.心血管研究中的临床与转化科学：2017年美国心脏协会科学会议亮点：对心血管风险概念和血压目标的观念转变
Cardiovasc Res. 2018 Jan 1;114(1):e6-e8. doi: 10.1093/cvr/cvx233.
8
Resistant Hypertension: An Update.顽固性高血压：最新进展
Am J Hypertens. 2019 Jan 1;32(1):1-3. doi: 10.1093/ajh/hpy156.
9
Blood pressure and the new ACC/AHA hypertension guidelines.血压与新的 ACC/AHA 高血压指南。
Trends Cardiovasc Med. 2020 Apr;30(3):160-164. doi: 10.1016/j.tcm.2019.05.003. Epub 2019 May 15.
10
Generalizability of Clinical Trials Supporting the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.支持 2017 年美国心脏病学会/美国心脏协会血压指南的临床试验的可推广性。
JAMA Intern Med. 2020 May 1;180(5):795-797. doi: 10.1001/jamainternmed.2020.0051.
引用本文的文献
1
Evaluation of Blood Pressure Control, Medication Adherence, and Therapeutic Inertia in US Patients With Hypertension Prescribed Multiple Antihypertensives.对美国接受多种抗高血压药物治疗的高血压患者的血压控制、药物依从性和治疗惰性的评估。
J Am Heart Assoc. 2025 Jun 17;14(12):e034787. doi: 10.1161/JAHA.124.034787. Epub 2025 Jun 16.
2
Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients.2018 年与 2008 年 AHA 定义的明显治疗抵抗性高血压在高危高血压患者中的患病率和预后。
J Clin Hypertens (Greenwich). 2020 Nov;22(11):2093-2102. doi: 10.1111/jch.14043. Epub 2020 Sep 20.
本文引用的文献
1
Incidence, prevalence, and predictors of treatment-resistant hypertension with intensive blood pressure lowering.强化降压治疗下的难治性高血压的发病率、患病率及预测因素。
J Clin Hypertens (Greenwich). 2019 Jun;21(6):825-834. doi: 10.1111/jch.13550. Epub 2019 May 7.
2
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.耐药性高血压：检测、评估与管理：美国心脏协会科学声明。
Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084.
3
Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD.在耐药性和非耐药性高血压中最佳收缩压目标：SPRINT 和 ACCORD 患者水平数据的汇总分析。
Am J Med. 2018 Dec;131(12):1463-1472.e7. doi: 10.1016/j.amjmed.2018.08.005. Epub 2018 Aug 22.
4
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药剂师协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Hypertension. 2018 Jun;71(6):e13-e115. doi: 10.1161/HYP.0000000000000065. Epub 2017 Nov 13.
5
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
6
Health-related quality of life in persons with apparent treatment-resistant hypertension on at least four antihypertensives.使用至少四种抗高血压药物但仍明显存在治疗抵抗的高血压患者的健康相关生活质量
J Hum Hypertens. 2016 Mar;30(3):191-6. doi: 10.1038/jhh.2015.61. Epub 2015 Jun 18.
7
Effects of intensive blood-pressure control in type 2 diabetes mellitus.强化血压控制对 2 型糖尿病的影响。
N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.
8
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.难治性高血压：诊断、评估与治疗。美国心脏协会高血压研究理事会专业教育委员会的科学声明。
Hypertension. 2008 Jun;51(6):1403-19. doi: 10.1161/HYPERTENSIONAHA.108.189141. Epub 2008 Apr 7.
Zotero 插件